Parkworth Wealth Management, Inc. Adma Biologics, Inc. Transaction History
Parkworth Wealth Management, Inc.
- $120 Billion
- Q4 2024
A detailed history of Parkworth Wealth Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Parkworth Wealth Management, Inc. holds 5 shares of ADMA stock, worth $104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5Holding current value
$104% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
342Shares Held
181MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$390 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$381 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$311 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$236 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$116 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...